周四盘中，医疗科技公司Phreesia, Inc.（股票代码：PHR）股价大涨5%，引发市场关注。这波涨势主要受到两家知名投资银行最新研究报告的推动。
据悉，加拿大投资银行集团和Truist Securities均维持了对Phreesia的"买入"评级。尽管加拿大投资银行集团将目标价从35美元小幅下调至34美元，但Truist Securities则将目标价从34美元上调至35美元。这两份报告传递出的积极信号似乎超过了轻微的目标价调整带来的影响。
分析人士指出，两家知名机构一致维持"买入"评级，显示出他们对Phreesia未来发展前景的信心。这种乐观态度可能激发了投资者的买入热情，推动了股价的快速上涨。然而，投资者仍需密切关注公司的基本面变化和未来的财务表现，以评估这一涨势是否具有持续性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.